Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations (Q30914737)

27 June 2017

title

Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations (English)

1 reference

27 June 2017

M Johansson

1

1 reference

27 June 2017

K Ranlund

series ordinal

2

1 reference

27 June 2017

K Lövgren-Bengtsson

series ordinal

3

1 reference

27 June 2017

publication date

1 July 2000

1 reference

27 June 2017

published in

Microbes and Infection

1 reference

27 June 2017

volume

2

1 reference

27 June 2017

issue

9

1 reference

27 June 2017

page(s)

1003-1010

1 reference

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Inflammatory response and antigen localization following immunization with influenza virus ISCOMs

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Influenza virus ISCOMs: biochemical characterization

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

Biodegradable poly(DL-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(00)01254-5

7 January 2021

10.1016/S1286-4579(00)01254-5

Identifiers

DOI

1 reference

27 June 2017

1 reference